RET-IN-8

• Description:

  RET-IN-8 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021093720A1 compound I-1. RET-IN-8 can be used for the research of cancer[1].

• UNSPSC:

  12352005

• Target:

  RET

• Type:

  Reference compound

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/ret-in-8.html

• Solubility:

  10 mM in DMSO

• Smiles:

  N#CC1=C2C(C3=CC=C(N4CCN(C([C@H](O)C(C)C)=O)CC4)N=C3)=CC(C5=CCOCC5)=CN2N=C1

• Molecular Formula:

  C27H30N6O3

• Molecular Weight:

  486.57

• References & Citations:

  [1]Gou J, et, al. Pyrazole[1,5-a]pyridine-3-nitrile compound and pharmaceutical use thereof. WO2021093720A1.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [2642164-75-6]